 | |
| | | Michael Garvey1,3,4
Independent Director
Mr. Garvey was with PricewaterhouseCoopers LLP from 1969 until his retirement in July 2006, including as an audit partner from 1982. He completed the Directors Education Programme at the University of Toronto in 2007 and has the ICD.D designation. He obtained his B.A. in Honours Economics from the University of Waterloo, his C.A. designation from the Institute of Chartered Accountants of Ontario which also elected him F.C.A. in 1985. He has volunteered his time to numerous charitable and professional activities throughout his career, including serving as Board Chair of The Donwood Institute, the University of Waterloo and The Michener Institute of Applied Health Sciences. He is a Director of Sherritt International Corporation, having joined the Board in May 2006. From June 19, 2007 to December 30, 2008, Mr. Garvey was a Director of MonoGen, Inc. (''Monogen''), which was incorporated under the Canada Business Corporations Act. On December 30, 2008, Monogen announced that it would make an assignment in bankruptcy at the end of that day. Effective January 13, 2009, the TSX suspended trading of Monogen's common shares and the shares were delisted on February 12, 2009.
|
.........................................................................
Notes:
(1) Member of the Audit Committee
(2) Member of the Nomination and Compensation Committee
(3) Member of the Corporate Governance Committee
(4) Member of the Health, Safety and Environment Committee
|
| | |
|
| |
